Zymeworks to merge with Theravance Biopharma
Zymeworks Inc. has entered into an agreement and plan of merger with Theravance Biopharma Inc. The deal, effective upon closing, includes terms for the exchange of securities and treatment of equity awards.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed